Apolipoprotein D

被引:259
作者
Rassart, E
Bedirian, A
Do Carmo, S
Guinard, O
Sirois, J
Terrisse, L
Milne, R
机构
[1] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada
[2] Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Grp, Ottawa, ON K1Y 4E9, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 2000年 / 1482卷 / 1-2期
关键词
apolipoprotein D; GCDFP-24; neurodegenerative disease; Alzheimer's disease; Niemann-Pick disease; regeneration; reinnervation;
D O I
10.1016/S0167-4838(00)00162-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein D (apoD) is a 29-kDa glycoprotein that is primarily associated with high density lipoproteins in human plasma. It is an atypical apolipoprotein and, based on its primary structure, apoD is predicted to be a member of the lipocalin family. Lipocalins adopt a beta -barrel tertiary structure and transport small hydrophobic ligands. Although apoD can bind cholesterol, progesterone, pregnenolone, bilirubin and arachidonic acid, it is unclear if any, or all of these, represent its physiological ligands. The apoD gene is expressed in many tissues, with high levels of expression in spleen, testes and brain. ApoD is present at high concentrations in the cyst fluid of women with gross cystic disease of the breast, a condition associated with increased risk of breast cancer. It also accumulates at sites of regenerating peripheral nerves and in the cerebrospinal fluid of patients with neurodegenerative conditions, such as Alzheimer's disease. ApoD may, therefore, participate in maintenance and repair within the central and peripheral nervous systems. While its role in metabolism has yet to be defined, apoD is likely to be a multi-ligand, multi-functional transporter. It could transport a ligand from one cell to another within an organ, scavenge a ligand within an organ for transport to the blood or could transport a ligand from the circulation to specific cells within a tissue. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:185 / 198
页数:14
相关论文
共 90 条
[1]   THE SERUM APOLIPOPROTEIN PROFILE OF PATIENTS WITH GLUCOSE-6-PHOSPHATASE DEFICIENCY [J].
ALAUPOVIC, P ;
FERNANDES, J .
PEDIATRIC RESEARCH, 1985, 19 (04) :380-384
[2]  
ALAUPOVIC P, 1974, SCAND J CLIN LAB INV, V33, P83
[3]   REDUCTION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE, APOLIPOPROTEIN D AND THE LP(A) LIPOPROTEIN WITH THE ANABOLIC-STEROID STANOZOLOL [J].
ALBERS, JJ ;
TAGGART, HM ;
APPLEBAUMBOWDEN, D ;
HAFFNER, S ;
CHESNUT, CH ;
HAZZARD, WR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 795 (02) :293-296
[4]   CHARACTERIZATION AND IMMUNOASSAY OF APOLIPOPROTEIN-D [J].
ALBERS, JJ ;
CHEUNG, MC ;
EWENS, SL ;
TOLLEFSON, JH .
ATHEROSCLEROSIS, 1981, 39 (03) :395-409
[5]  
[Anonymous], DIS BREAST
[6]   DIFFERENTIAL EXPRESSION OF APOLIPOPROTEIN-D AND PROSTATE-SPECIFIC ANTIGEN IN BENIGN AND MALIGNANT PROSTATE TISSUES [J].
ASPINALL, JO ;
BENTEL, JM ;
HORSFALL, DJ ;
HAAGENSEN, DE ;
MARSHALL, VR ;
TILLEY, WD .
JOURNAL OF UROLOGY, 1995, 154 (02) :622-628
[7]  
AYRAULTJARRIER M, 1963, B SOC CHIM BIOL, V45, P703
[8]   APOLIPOPROTEIN-D GENE POLYMORPHISM - A NEW GENETIC-MARKER FOR TYPE-2 DIABETIC SUBJECTS IN NAURU AND SOUTH-INDIA [J].
BAKER, WA ;
HITMAN, GA ;
HAWRAMI, K ;
MCCARTHY, MI ;
RIIKONEN, A ;
TUOMILEHTOWOLF, E ;
NISSINEN, A ;
TUOMILEHTO, J ;
MOHAN, V ;
VISWANATHAN, M ;
SNEHALATHA, C ;
RAMACHANDRAN, A ;
DOWSE, GK ;
ZIMMET, P ;
SERJEANTSON, SW .
DIABETIC MEDICINE, 1994, 11 (10) :947-952
[9]   APOLIPOPROTEIN-D IS THE MAJOR PROTEIN-COMPONENT IN CYST FLUID FROM WOMEN WITH HUMAN BREAST GROSS CYSTIC-DISEASE [J].
BALBIN, M ;
FREIJE, JMP ;
FUEYO, A ;
SANCHEZ, LM ;
LOPEZOTIN, C .
BIOCHEMICAL JOURNAL, 1990, 271 (03) :803-807
[10]   STATIONARY-PHASE EXPRESSION OF A NOVEL ESCHERICHIA-COLI OUTER-MEMBRANE LIPOPROTEIN AND ITS RELATIONSHIP WITH MAMMALIAN APOLIPOPROTEIN-D - IMPLICATIONS FOR THE ORIGIN OF LIPOCALINS [J].
BISHOP, RE ;
PENFOLD, SS ;
FROST, LS ;
HOLTJE, JV ;
WEINER, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (39) :23097-23103